1 | update | 2,378 |
2 | overview | 2,357 |
3 | umbrella | 59 |
4 | encyclopedia | 37 |
5 | upsurge | 27 |
6 | iteration | 22 |
7 | epiphenomenon | 21 |
8 | affiliate | 11 |
9 | addendum | 8 |
10 | mpk | 8 |
11 | oleo-gum-resin | 6 |
12 | review.the | 6 |
13 | academician | 4 |
14 | alarm-clock | 4 |
15 | outsider | 4 |
16 | underprediction | 4 |
17 | understatement | 4 |
18 | investigator-designed | 3 |
19 | mdrmse | 3 |
20 | outpouring | 3 |
21 | overincidence | 3 |
22 | oversample | 3 |
23 | r-spike | 3 |
24 | rareness | 3 |
25 | up-date | 3 |
26 | α-level | 3 |
27 | 'energizer | 2 |
28 | 'eyeball | 2 |
29 | aminoglycoside-antibiotic | 2 |
30 | anchorless | 2 |
31 | apache-ii-score | 2 |
32 | area.date | 2 |
33 | epi-analysis | 2 |
34 | ethno-directed | 2 |
35 | extra-cost | 2 |
36 | f-score | 2 |
37 | improbability | 2 |
38 | mechanism-driven | 2 |
39 | orally-bioavailable | 2 |
40 | ordinal-scale | 2 |
41 | 'approved | 1 |
42 | 'assignation | 1 |
43 | 11-residue | 1 |
44 | abundancy | 1 |
45 | acutization | 1 |
46 | air-sheet | 1 |
47 | aldrete- | 1 |
48 | alkylation/cycloisomerization | 1 |
49 | all-sct | 1 |
50 | aln-group | 1 |
51 | alpha-threshold | 1 |
52 | ammo-niate | 1 |
53 | analiysis | 1 |
54 | anti-activator | 1 |
55 | anti-aristolochic | 1 |
56 | anti-cluster | 1 |
57 | anverage | 1 |
58 | apnea- | 1 |
59 | archiater | 1 |
60 | arthrocare® | 1 |
61 | autoradiogram | 1 |
62 | avenge | 1 |
63 | aza-michael/alkyne | 1 |
64 | cycloaddition/hydroarylation | 1 |
65 | cyclodepsipeptide | 1 |
66 | datafile | 1 |
67 | demedicalization | 1 |
68 | e/z-mixture | 1 |
69 | economisation | 1 |
70 | ed50-value | 1 |
71 | egg-endoparasitoid | 1 |
72 | eight-episode | 1 |
73 | eight-node | 1 |
74 | electron-enriched | 1 |
75 | electronically-derived | 1 |
76 | encylopedia | 1 |
77 | enhancer/carrier | 1 |
78 | eply | 1 |
79 | equilibriumlike | 1 |
80 | evaluation-questionnaire | 1 |
81 | evaluation.records | 1 |
82 | everage | 1 |
83 | extensile | 1 |
84 | extra-dose | 1 |
85 | extra-expenses | 1 |
86 | fecl2-promoted | 1 |
87 | fpv/e | 1 |
88 | hba1c-level | 1 |
89 | hdl-c-increment | 1 |
90 | ic100 | 1 |
91 | incentive-compatible | 1 |
92 | infant-sized | 1 |
93 | inquiry.results | 1 |
94 | intergenotype | 1 |
95 | interval-difference | 1 |
96 | intervention-yo | 1 |
97 | intervention/follow-up | 1 |
98 | interventionsin | 1 |
99 | interweaving | 1 |
100 | isobath | 1 |
101 | lay-summary | 1 |
102 | ld30/60 | 1 |
103 | ld70/60 | 1 |
104 | lod-score | 1 |
105 | macro-modification | 1 |
106 | mc2r | 1 |
107 | n-α-phenylacryloyl | 1 |
108 | ncaa-sponsored | 1 |
109 | nwgr | 1 |
110 | o3-bioindicator | 1 |
111 | off-centering | 1 |
112 | online-navigated | 1 |
113 | online-service | 1 |
114 | oralformulation | 1 |
115 | orf1b-based | 1 |
116 | organic-functional | 1 |
117 | organic-solvent-based | 1 |
118 | organisation/group | 1 |
119 | overexcitation | 1 |
120 | overinvestment | 1 |
121 | overwiew | 1 |
122 | pathological-stimulation | 1 |
123 | population.a | 1 |
124 | rct-d | 1 |
125 | rd50 | 1 |
126 | reauthorization | 1 |
127 | review.types | 1 |
128 | rmerge | 1 |
129 | sec-icp-ms-based | 1 |
130 | ssri:1. | 1 |
131 | study.out | 1 |
132 | ultron | 1 |
133 | undercurrent | 1 |
134 | unpregulation | 1 |
135 | up-modulation | 1 |
136 | up-regulator | 1 |
137 | update.meta-analysis | 1 |
138 | update.quality | 1 |
139 | way.we | 1 |
140 | ¹¹¹in-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic | 1 |
141 | α-d-apio-l-furanoadenosine | 1 |
142 | α-risk | 1 |
1 | 'approved | 1 |
2 | 'assignation | 1 |
3 | 'energizer | 2 |
4 | 'eyeball | 2 |
5 | 11-residue | 1 |
6 | abundancy | 1 |
7 | academician | 4 |
8 | acutization | 1 |
9 | addendum | 8 |
10 | affiliate | 11 |
11 | air-sheet | 1 |
12 | alarm-clock | 4 |
13 | aldrete- | 1 |
14 | alkylation/cycloisomerization | 1 |
15 | all-sct | 1 |
16 | aln-group | 1 |
17 | alpha-threshold | 1 |
18 | aminoglycoside-antibiotic | 2 |
19 | ammo-niate | 1 |
20 | analiysis | 1 |
21 | anchorless | 2 |
22 | anti-activator | 1 |
23 | anti-aristolochic | 1 |
24 | anti-cluster | 1 |
25 | anverage | 1 |
26 | apache-ii-score | 2 |
27 | apnea- | 1 |
28 | archiater | 1 |
29 | area.date | 2 |
30 | arthrocare® | 1 |
31 | autoradiogram | 1 |
32 | avenge | 1 |
33 | aza-michael/alkyne | 1 |
34 | cycloaddition/hydroarylation | 1 |
35 | cyclodepsipeptide | 1 |
36 | datafile | 1 |
37 | demedicalization | 1 |
38 | e/z-mixture | 1 |
39 | economisation | 1 |
40 | ed50-value | 1 |
41 | egg-endoparasitoid | 1 |
42 | eight-episode | 1 |
43 | eight-node | 1 |
44 | electron-enriched | 1 |
45 | electronically-derived | 1 |
46 | encyclopedia | 37 |
47 | encylopedia | 1 |
48 | enhancer/carrier | 1 |
49 | epi-analysis | 2 |
50 | epiphenomenon | 21 |
51 | eply | 1 |
52 | equilibriumlike | 1 |
53 | ethno-directed | 2 |
54 | evaluation-questionnaire | 1 |
55 | evaluation.records | 1 |
56 | everage | 1 |
57 | extensile | 1 |
58 | extra-cost | 2 |
59 | extra-dose | 1 |
60 | extra-expenses | 1 |
61 | f-score | 2 |
62 | fecl2-promoted | 1 |
63 | fpv/e | 1 |
64 | hba1c-level | 1 |
65 | hdl-c-increment | 1 |
66 | ic100 | 1 |
67 | improbability | 2 |
68 | incentive-compatible | 1 |
69 | infant-sized | 1 |
70 | inquiry.results | 1 |
71 | intergenotype | 1 |
72 | interval-difference | 1 |
73 | intervention-yo | 1 |
74 | intervention/follow-up | 1 |
75 | interventionsin | 1 |
76 | interweaving | 1 |
77 | investigator-designed | 3 |
78 | isobath | 1 |
79 | iteration | 22 |
80 | lay-summary | 1 |
81 | ld30/60 | 1 |
82 | ld70/60 | 1 |
83 | lod-score | 1 |
84 | macro-modification | 1 |
85 | mc2r | 1 |
86 | mdrmse | 3 |
87 | mechanism-driven | 2 |
88 | mpk | 8 |
89 | n-α-phenylacryloyl | 1 |
90 | ncaa-sponsored | 1 |
91 | nwgr | 1 |
92 | o3-bioindicator | 1 |
93 | off-centering | 1 |
94 | oleo-gum-resin | 6 |
95 | online-navigated | 1 |
96 | online-service | 1 |
97 | oralformulation | 1 |
98 | orally-bioavailable | 2 |
99 | ordinal-scale | 2 |
100 | orf1b-based | 1 |
101 | organic-functional | 1 |
102 | organic-solvent-based | 1 |
103 | organisation/group | 1 |
104 | outpouring | 3 |
105 | outsider | 4 |
106 | overexcitation | 1 |
107 | overincidence | 3 |
108 | overinvestment | 1 |
109 | oversample | 3 |
110 | overview | 2,357 |
111 | overwiew | 1 |
112 | pathological-stimulation | 1 |
113 | population.a | 1 |
114 | r-spike | 3 |
115 | rareness | 3 |
116 | rct-d | 1 |
117 | rd50 | 1 |
118 | reauthorization | 1 |
119 | review.the | 6 |
120 | review.types | 1 |
121 | rmerge | 1 |
122 | sec-icp-ms-based | 1 |
123 | ssri:1. | 1 |
124 | study.out | 1 |
125 | ultron | 1 |
126 | umbrella | 59 |
127 | undercurrent | 1 |
128 | underprediction | 4 |
129 | understatement | 4 |
130 | unpregulation | 1 |
131 | up-date | 3 |
132 | up-modulation | 1 |
133 | up-regulator | 1 |
134 | update | 2,378 |
135 | update.meta-analysis | 1 |
136 | update.quality | 1 |
137 | upsurge | 27 |
138 | way.we | 1 |
139 | ¹¹¹in-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic | 1 |
140 | α-d-apio-l-furanoadenosine | 1 |
141 | α-level | 3 |
142 | α-risk | 1 |
1 | apnea- | 1 |
2 | aldrete- | 1 |
3 | ssri:1. | 1 |
4 | ic100 | 1 |
5 | rd50 | 1 |
6 | ld30/60 | 1 |
7 | ld70/60 | 1 |
8 | population.a | 1 |
9 | encyclopedia | 37 |
10 | encylopedia | 1 |
11 | umbrella | 59 |
12 | anti-aristolochic | 1 |
13 | ¹¹¹in-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic | 1 |
14 | aminoglycoside-antibiotic | 2 |
15 | rct-d | 1 |
16 | electron-enriched | 1 |
17 | investigator-designed | 3 |
18 | ncaa-sponsored | 1 |
19 | orf1b-based | 1 |
20 | sec-icp-ms-based | 1 |
21 | organic-solvent-based | 1 |
22 | online-navigated | 1 |
23 | ethno-directed | 2 |
24 | fecl2-promoted | 1 |
25 | electronically-derived | 1 |
26 | 'approved | 1 |
27 | infant-sized | 1 |
28 | egg-endoparasitoid | 1 |
29 | alpha-threshold | 1 |
30 | fpv/e | 1 |
31 | online-service | 1 |
32 | overincidence | 3 |
33 | interval-difference | 1 |
34 | cyclodepsipeptide | 1 |
35 | eight-node | 1 |
36 | eight-episode | 1 |
37 | everage | 1 |
38 | anverage | 1 |
39 | avenge | 1 |
40 | rmerge | 1 |
41 | upsurge | 27 |
42 | review.the | 6 |
43 | equilibriumlike | 1 |
44 | r-spike | 3 |
45 | ordinal-scale | 2 |
46 | orally-bioavailable | 2 |
47 | incentive-compatible | 1 |
48 | datafile | 1 |
49 | extensile | 1 |
50 | oversample | 3 |
51 | α-d-apio-l-furanoadenosine | 1 |
52 | aza-michael/alkyne | 1 |
53 | intergenotype | 1 |
54 | evaluation-questionnaire | 1 |
55 | lod-score | 1 |
56 | f-score | 2 |
57 | apache-ii-score | 2 |
58 | e/z-mixture | 1 |
59 | mdrmse | 3 |
60 | extra-dose | 1 |
61 | up-date | 3 |
62 | area.date | 2 |
63 | update | 2,378 |
64 | affiliate | 11 |
65 | ammo-niate | 1 |
66 | 11-residue | 1 |
67 | ed50-value | 1 |
68 | way.we | 1 |
69 | off-centering | 1 |
70 | outpouring | 3 |
71 | interweaving | 1 |
72 | isobath | 1 |
73 | alarm-clock | 4 |
74 | mpk | 8 |
75 | α-risk | 1 |
76 | organic-functional | 1 |
77 | hba1c-level | 1 |
78 | α-level | 3 |
79 | 'eyeball | 2 |
80 | n-α-phenylacryloyl | 1 |
81 | autoradiogram | 1 |
82 | addendum | 8 |
83 | academician | 4 |
84 | mechanism-driven | 2 |
85 | oleo-gum-resin | 6 |
86 | interventionsin | 1 |
87 | macro-modification | 1 |
88 | up-modulation | 1 |
89 | unpregulation | 1 |
90 | pathological-stimulation | 1 |
91 | oralformulation | 1 |
92 | cycloaddition/hydroarylation | 1 |
93 | 'assignation | 1 |
94 | iteration | 22 |
95 | economisation | 1 |
96 | overexcitation | 1 |
97 | demedicalization | 1 |
98 | alkylation/cycloisomerization | 1 |
99 | reauthorization | 1 |
100 | acutization | 1 |
101 | underprediction | 4 |
102 | epiphenomenon | 21 |
103 | ultron | 1 |
104 | intervention-yo | 1 |
105 | intervention/follow-up | 1 |
106 | aln-group | 1 |
107 | organisation/group | 1 |
108 | mc2r | 1 |
109 | outsider | 4 |
110 | enhancer/carrier | 1 |
111 | archiater | 1 |
112 | anti-cluster | 1 |
113 | 'energizer | 2 |
114 | nwgr | 1 |
115 | o3-bioindicator | 1 |
116 | up-regulator | 1 |
117 | anti-activator | 1 |
118 | evaluation.records | 1 |
119 | review.types | 1 |
120 | extra-expenses | 1 |
121 | analiysis | 1 |
122 | update.meta-analysis | 1 |
123 | epi-analysis | 2 |
124 | anchorless | 2 |
125 | rareness | 3 |
126 | inquiry.results | 1 |
127 | all-sct | 1 |
128 | air-sheet | 1 |
129 | hdl-c-increment | 1 |
130 | understatement | 4 |
131 | overinvestment | 1 |
132 | undercurrent | 1 |
133 | extra-cost | 2 |
134 | study.out | 1 |
135 | overview | 2,357 |
136 | overwiew | 1 |
137 | abundancy | 1 |
138 | eply | 1 |
139 | lay-summary | 1 |
140 | update.quality | 1 |
141 | improbability | 2 |
142 | arthrocare® | 1 |